Literature DB >> 26836192

Posterior Accumulation of Tau and Concordant Hypometabolism in an Early-Onset Alzheimer's Disease Patient with Presenilin-1 Mutation.

Ruben Smith1, Moa Wibom2, Tomas Olsson3, Douglas Hägerström4, Jonas Jögi5, Gil D Rabinovici6, Oskar Hansson7.   

Abstract

It is unclear whether the distribution of tau pathology differs between cases with early-onset familial Alzheimer's disease (AD) and sporadic AD. We present positron emission tomography (PET) data from a young patient with a presenilin-1 mutation (Thr116Asn). 18F-flutemetamol PET showed a distribution of amyloid-β fibrils similar to sporadic AD. However, the pattern of tau pathology, revealed using 18F-AV1451 PET, showed higher uptake in posterior cingulate, precuneus, parietal and occipital cortices compared to late-onset sporadic AD. Further, the tau pathology, but not amyloid pathology, exhibited a very clear inverse relationship with 18F-fluorodeoxyglucose-metabolism, indicating neuronal hypometabolism in regions affected by tau aggregates.

Entities:  

Keywords:  Alzheimer’s disease; positron-emission tomography; presenilins; tau proteins

Mesh:

Substances:

Year:  2016        PMID: 26836192     DOI: 10.3233/JAD-151004

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  16 in total

1.  Correlation of In Vivo [18F]Flortaucipir With Postmortem Alzheimer Disease Tau Pathology.

Authors:  Ruben Smith; Moa Wibom; Daria Pawlik; Elisabet Englund; Oskar Hansson
Journal:  JAMA Neurol       Date:  2019-03-01       Impact factor: 18.302

2.  Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease.

Authors:  Chenjie Xia; Sara J Makaretz; Christina Caso; Scott McGinnis; Stephen N Gomperts; Jorge Sepulcre; Teresa Gomez-Isla; Bradley T Hyman; Aaron Schultz; Neil Vasdev; Keith A Johnson; Bradford C Dickerson
Journal:  JAMA Neurol       Date:  2017-04-01       Impact factor: 18.302

Review 3.  Tau Imaging in Alzheimer's Disease Diagnosis and Clinical Trials.

Authors:  Jared R Brosch; Martin R Farlow; Shannon L Risacher; Liana G Apostolova
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

4.  Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers.

Authors:  Brian A Gordon; Tyler M Blazey; Jon Christensen; Aylin Dincer; Shaney Flores; Sarah Keefe; Charles Chen; Yi Su; Eric M McDade; Guoqiao Wang; Yan Li; Jason Hassenstab; Andrew Aschenbrenner; Russ Hornbeck; Clifford R Jack; Beau M Ances; Sarah B Berman; Jared R Brosch; Douglas Galasko; Serge Gauthier; James J Lah; Mario Masellis; Christopher H van Dyck; Mark A Mintun; Gregory Klein; Smiljana Ristic; Nigel J Cairns; Daniel S Marcus; Chengjie Xiong; David M Holtzman; Marcus E Raichle; John C Morris; Randall J Bateman; Tammie L S Benzinger
Journal:  Brain       Date:  2019-04-01       Impact factor: 13.501

5.  Neuropathology and biochemistry of early onset familial Alzheimer's disease caused by presenilin-1 missense mutation Thr116Asn.

Authors:  Stanislav Sutovsky; Tomas Smolek; Peter Turcani; Robert Petrovic; Petra Brandoburova; Santosh Jadhav; Petr Novak; Johannes Attems; Norbert Zilka
Journal:  J Neural Transm (Vienna)       Date:  2018-02-05       Impact factor: 3.575

6.  18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers.

Authors:  Ruben Smith; Andreas Puschmann; Michael Schöll; Tomas Ohlsson; John van Swieten; Michael Honer; Elisabet Englund; Oskar Hansson
Journal:  Brain       Date:  2016-06-29       Impact factor: 13.501

7.  In vivo retention of 18F-AV-1451 in corticobasal syndrome.

Authors:  Ruben Smith; Michael Schöll; Håkan Widner; Danielle van Westen; Per Svenningsson; Douglas Hägerström; Tomas Ohlsson; Jonas Jögi; Christer Nilsson; Oskar Hansson
Journal:  Neurology       Date:  2017-07-28       Impact factor: 9.910

8.  18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease.

Authors:  Niklas Mattsson; Michael Schöll; Olof Strandberg; Ruben Smith; Sebastian Palmqvist; Philip S Insel; Douglas Hägerström; Tomas Ohlsson; Henrik Zetterberg; Jonas Jögi; Kaj Blennow; Oskar Hansson
Journal:  EMBO Mol Med       Date:  2017-09       Impact factor: 12.137

Review 9.  Neuroimaging in aging and neurologic diseases.

Authors:  Shannon L Risacher; Andrew J Saykin
Journal:  Handb Clin Neurol       Date:  2019

10.  Amyloid imaging and Alzheimer's disease: the unsolved cases.

Authors:  Michael J O'Sullivan; Seralynne D Vann
Journal:  Brain       Date:  2016-09       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.